Why is Trump’s bill causing record 2026 tax refunds?
How is China easing chip export restrictions?
What impact is GM's EV pullback having?
Why are airlines urging Congress to end shutdown?
How is Nvidia’s $1B investment affecting Nokia?
Why are SNAP food benefits at risk now?
What caused Verizon’s customer losses recently?
Indian pharma giant says Health Canada rejected its application to make generic semaglutide
theglobeandmail.com/business/article-dr-reddys-laboratories-health-canada-rejected-application-generic
Indian pharma giant Dr. Reddy’s Laboratories Ltd. says Health Canada has rejected its application to make generic semaglutide, a setback for what was poised to be one of the first generic competitors to Ozempic to hit the market in 2026.
Ozempic, made by Danish drugmaker Novo Nordisk…
This story appeared on theglobeandmail.com, 2025-10-29 23:50:30.